Dart NeuroScience LLC - Product Pipeline Review - 2014

Published: Jul, 2014 | Pages: 38 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Dart NeuroScience LLC - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Dart NeuroScience LLC - Product Pipeline Review - 2014', provides an overview of the Dart NeuroScience LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Dart NeuroScience LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Dart NeuroScience LLC including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Dart NeuroScience LLC's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Dart NeuroScience LLC's pipeline products

Reasons to buy

- Evaluate Dart NeuroScience LLC's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Dart NeuroScience LLC in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Dart NeuroScience LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Dart NeuroScience LLC and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Dart NeuroScience LLC
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Dart NeuroScience LLC and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Dart NeuroScience LLC Snapshot 5
Dart NeuroScience LLC Overview 5
Key Information 5
Key Facts 5
Dart NeuroScience LLC - Research and Development Overview 6
Key Therapeutic Areas 6
Dart NeuroScience LLC - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Dart NeuroScience LLC - Pipeline Products Glance 11
Dart NeuroScience LLC - Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
Dart NeuroScience LLC - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Discovery Products/Combination Treatment Modalities 14
Dart NeuroScience LLC - Drug Profiles 15
HT-0712 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
HT-2157 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
HT-1067 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
HT-3951 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Small Molecule 5 for Cognitive Impairment 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Small Molecule 1 for Cognitive Impairment 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Small Molecule 2 for Cognitive Impairment 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Small Molecule 3 for Cognitive Impairment 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Small Molecule 4 for Cognitive Impairment 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Small Molecule 6 for Cognitive Impairment 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Small Molecule to Inhibit GlyT-1 for Cognitive Impairment 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Small Molecules Targeting GABAA Receptor for Cognitive Impairment 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Small Molecules Targeting GALR3 for Memory Impairment and Depression 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Small Molecules Targeting PDE4 for Memory Impairment 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Small Molecules to Inhibit Glyt-1 for Cognitive Impairment 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Dart NeuroScience LLC - Pipeline Analysis 30
Dart NeuroScience LLC - Pipeline Products by Target 30
Dart NeuroScience LLC - Pipeline Products by Route of Administration 31
Dart NeuroScience LLC - Pipeline Products by Molecule Type 32
Dart NeuroScience LLC - Pipeline Products by Mechanism of Action 33
Dart NeuroScience LLC - Recent Pipeline Updates 34
Dart NeuroScience LLC - Discontinued Pipeline Products 35
Discontinued Pipeline Product Profiles 35
HT-2678 35
Dart NeuroScience LLC - Locations And Subsidiaries 36
Head Office 36
Appendix 37
Methodology 37
Coverage 37
Secondary Research 37
Primary Research 37
Expert Panel Validation 37
Contact Us 38
Disclaimer 38

List of Tables
Dart NeuroScience LLC, Key Information 5
Dart NeuroScience LLC, Key Facts 5
Dart NeuroScience LLC - Pipeline by Indication, 2014 8
Dart NeuroScience LLC - Pipeline by Stage of Development, 2014 9
Dart NeuroScience LLC - Monotherapy Products in Pipeline, 2014 10
Dart NeuroScience LLC - Phase II, 2014 11
Dart NeuroScience LLC - Phase I, 2014 12
Dart NeuroScience LLC - Preclinical, 2014 13
Dart NeuroScience LLC - Discovery, 2014 14
Dart NeuroScience LLC - Pipeline by Target, 2014 30
Dart NeuroScience LLC - Pipeline by Route of Administration, 2014 31
Dart NeuroScience LLC - Pipeline by Molecule Type, 2014 32
Dart NeuroScience LLC - Pipeline Products by Mechanism of Action, 2014 33
Dart NeuroScience LLC - Recent Pipeline Updates, 2014 34
Dart NeuroScience LLC - Discontinued Pipeline Products, 2014 35